MM

Milestone Medical IncWSE Milestone Stock Report

Last reporting period 30 Sep, 2023

Updated 11 Oct, 2024

Last price

Market cap $B

0.045

Micro

Exchange

XWAR - Warsaw Stock Exchange

MMD.WA Stock Analysis

MM

Uncovered

Milestone Medical Inc is uncovered by Eyestock quantitative analysis.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

-73/100

Low score

Market cap $B

0.045

Dividend yield

Shares outstanding

22 B

Milestone Medical, Inc. engages in the development and commercialization of epidural and intra-articular drug delivery systems. The company is headquartered in Roseland, New Jersey. The company went IPO on 2013-11-28. Its CompuFlo Epidural Computer Controlled Anesthesia System is providing anesthesiologists and other healthcare providers the ability to determine and document the pressure at the needle tip in real-time for needle placement in epidural procedures used for labor/delivery and back pain management. Its DPS Dynamic Pressure Sensing Technology allows the CompuFlo Epidural System to provide objective visual and audible in-tissue pressure feedback. Its CompuFlo Epidural System provides an objective tool that identifies the epidural space by detecting the difference in pressure between the ligamentum flavum and the intrafilamentary tissue. The Company’s products include medical instruments, handpieces/disposables, and other related products.

View Section: Eyestock Rating